Sentences with phrase «private biotechnology company»

Z o.o is a private biotechnology company founded in 2012.

About Everon Biosciences Everon Biosciences, Inc. is a private biotechnology company focused on developing novel anti-aging therapeutics.

Everon Biosciences, Inc. a private biotechnology company focused on developing novel anti-aging therapeutics.

The antibody - based assay, developed by researchers at UC Berkeley and Humabs BioMed, a private biotechnology company, is a simple, cost - effective way to determine if a person's infection is from the Zika virus or another virus of the same family, such as dengue and West Nile viruses.

My qualitative postdoctoral research project is focusing on the role of private biotechnology companies in addressing local health needs in developing countries; it will involve travel to several countries, including China, India, Brazil, and South Africa.

Not exact matches

«Since the inception of the University - Industry Liaison Office [UILO] in 1984, UBC has spun off 91 companies, while raising more than CA$ 1.3 billion from private investors,» says Paul Stinson, executive director of BC Biotech, an organization created 10 years ago to promote and aid the development of biotechnology in BC.

Roughly three - quarters of respondents work in private industry, with 47 percent employed by biotechnology companies, 33 percent in pharmas, and the remaining 20 percent in biopharmas.

California hosts a range of life science employers: hundreds of biotechnology and pharmaceutical companies, state and private academic institutions, private research organizations, and government laboratories.

Finally, students need to be made more aware of the job opportunities available to them in the private sector, which can be accomplished through university - sponsored job fairs, guest lecturers from the life sciences industry, and visits to local biotechnology and pharmaceutical companies.

(b) The University of California is requested to utilize California's unique collaborative research environment by convening stakeholders from public and private research institutions, national laboratories, biotechnology and high technology companies, and venture capital firms to develop the governing structure for the Cal - BRAIN program.

We also nurture start - ups for scientists so that they can bring medical inventions to market, and we've partnered with leading biotechnology and technology companies such as Genentech, Pfizer, GE and Samsung to leverage the best public and private sector expertise to solve the biggest problems in health.

Biotech Showcase ™, produced by Demy - Colton and EBD Group, is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives during the course of one of the industry's largest annual healthcare investor conferences.

He has served on twenty - two public or private companies active in software, electronics, biotechnology, computer, telecommunication, consumer product, solar power and education markets.

Before IGC, Abhijeet spent 10 years as a Managing Member of EGS Healthcare Capital Partners, a venture capital firm focusing on private and public investments in biotechnology, specialty pharmaceutical and medical device companies.

In addition to prosecuting patent applications on behalf of public and private institutions, biotechnology companies, and pharmaceutical companies, Dr. Rearick performs IP due diligence in a variety of in - licensing and investment contexts, with specific expertise in pharmaceuticals.

These include start - up enterprises and ongoing private and public companies engaged in any number of fields such as biotechnology, medical devices, software and computers, electronics, health care, telecommunications, banking and financial services.

Spanning our corporate, intellectual property and litigation practices, our legal team helps biotechnology and pharmaceutical companies — both public and private, large and small — solve their legal problems at every stage of growth.

Our corporate attorneys represent clients in the biotechnology and life sciences industry regardless of whether those clients are not - for - profit entities, emerging companies or multi-million dollar private or public companies.

She has extensive experience in senior management positions in the public and private sectors, including six years as CEO of an ASX — listed biotechnology company.